Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Online Toolkit to Standardize Measures and Protocols in Genetic Research

By LabMedica International staff writers
Posted on 06 May 2009
Scientists who conduct genetic studies will now have a new set of tools to refine estimates of disease risk and extend the findings of one study to other studies or across population groups. More...
The tools, a set of standard measures and research protocols, are part of a U.S. effort designed to accelerate understanding of the complicated genetic and environmental factors associated with cancer, heart disease, depression, and many other common diseases.

Collectively called the PhenX Toolkit, the measures and protocols were developed as part of the three-year collaborative research effort, called PhenX (pronounced "phoenix"), which is a combination of the words phenotype and exposures. The effort, being led by the independent, nonprofit research organization RTI International (Research Triangle Park, NC, USA), is funded by the U.S. National Institutes of Health's National Human Genome Research Institute (Bethesda, MD, USA). "The use of standard measures is vital to furthering our knowledge of the many complex relationships between genetics, environmental factors, and common diseases," said Carol M. Hamilton, Ph.D., director of bioinformatics at RTI and the project's lead investigator.

The initial release of the toolkit includes the high-priority measures selected by panels with expertise in demographics; anthropometrics (measures of body size and proportion); and alcohol, tobacco, and other substances. Experts in the cardiovascular field, as well as those with expertise in nutrition and dietary supplements, are currently working to identify measures that will be added to the toolkit within the next few months.

In all, the toolkit is expected to include about 300 high-priority measures covering a range of conditions and exposures relevant to common diseases. Users of the toolkit can browse measures and protocols, search using keywords, generate reports, and select measures for use in their studies. The use of consensus measures in their studies allows researchers to pool study results, increase the capability to identify associations, and facilitate comparison of different studies.

The initial measures and protocols were developed over the past 12 months by three expert panels, with contributions from more than 100 scientists from diverse scientific and health disciplines who participated or served as reviewers.

RTI International is one of the world's leading research institutes, focused on improving the human condition by turning knowledge into practice. The company's staff of more than 2,800 provides research and technical expertise to governments and businesses in more than 40 countries in the areas of health and pharmaceuticals, education and training, surveys and statistics, advanced technology, international development, economic and social policy, energy and the environment, and laboratory and chemistry services.

Related Links:

RTI International



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Drug Test Kit
DrugCheck 3000
New
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.